Home Add to Favorite Contact Submit  
           16 May, 2021


    
Category:  Press » Health & Fitness

 

Corgentech Pain Drug, 4975, Demonstrates Statistically Significant Pain Reduction After Knee Replacement Surgeries

Popularity:
         Views: 1993
2006-06-14 04:41:52     
Corgentech Inc.

Corgentech Inc. (Nasdaq: CGTK) today reported positive, top-line clinical data from a Phase 2 clinical trial in total knee replacement surgeries showing that 4975, the company's novel, long-acting, non-opioid drug candidate being developed for site-specific, moderate-to-severe pain, demonstrated pain reduction at all pre-specified time intervals in the study, including statistically significant pain relief at day one (p=0.0273) and at day 14 (p=0.0071).

The difference in average daily pain scores between the 4975-treated group (n=25) and the placebo group (n=25) on day one was statistically significant and showed a relative difference in pain on first ambulation of 24 percent. On a numerical rating scale of zero to 10, the average pain score for the treated group was 5.4 compared with the placebo group's average of 7.1. It is noteworthy that this difference was detected despite all patients being on concomitant morphine. On day 14, the patients' "worst pain in the previous 24-hour period" using the Brief Pain Inventory form showed a relative difference of 34 percent with the average pain scores being 3.9 and 5.9 for the treated group and placebo group, respectively.

The analysis of additional exploratory efficacy endpoints favored the 4975 group over the placebo group including average daily pain scores at multiple time points: day 1, day 2, days 1-2, days 3-7, days 8-14, days 1-14 and days 3-14. In addition, the measure of pain interference with activities favored the 4975 group over the placebo group at most of the time points measured. The preliminary data showed that 4975 was safe and well tolerated.

Total knee replacement (also known as total knee arthroplasty) is performed in patients with end-stage osteoarthritis of the knee. These patients have disabling pain which imposes severe limitations on their mobility, and knee replacement is performed with the goal of restoring or improving patients' quality of life. There were an estimated 470,000 total knee replacement procedures performed in the United States in 2005, and the number of replacements will continue to grow as the average age of the U.S. population increases and as these individuals conduct more active lives. The American Academy of Orthopedic Surgery projects that approximately 3.5 million of these procedures will be done each year by 2030.

"4975 has demonstrated its ability to provide relief of acute and chronic pain to patients experiencing post-surgical, neuropathic and musculoskeletal pain for weeks to months after only a single, local administration. Unlike opioids, which have systemic side effects including nausea, vomiting, constipation and respiratory depression, 4975 appears to have a more favorable safety profile," said Daniel J. Gennevois, M.D., vice president of medical affairs at Corgentech. "Leveraging the positive data from the knee replacement trial in conjunction with the large body of 4975 clinical data collected to date, we look forward to discussing the data with regulators as we advance the clinical development of 4975."

The Phase 2 study involved 50 knee replacement surgery patients who were randomized to receive either a single dose of 4975 or placebo, which was dripped by syringe into the wound prior to closure. Post-operatively, patients self-administered intravenous morphine via patient controlled analgesia (PCA) pump to achieve satisfactory analgesia. Additionally, after PCA was discontinued, patients could receive supplemental hydrocodone/acetaminophen as needed to manage their pain.

Phase 2 Trial of 4975 for Cholecystectomy Surgery

The company also reported that in a Phase 2 trial of 4975 in 44 patients undergoing cholecystectomy (gall bladder removal) surgeries, the trial did not show a difference in pain scores between those receiving 4975 and those receiving placebo. The patients were randomized to receive either a single dose of 4975 or placebo, which was dripped by syringe into the surgical wound prior to closure, and both treatment groups received concomitant pain medications. Preliminary data show that 4975 was safe and well tolerated in this study. While both the knee and cholecystectomy trials were in surgical settings and included similar concentrations of 4975, it is possible that the extent of contact between the drug and the relevant tissues in the cholecystectomy surgeries may not have been maintained at a level sufficient to provide therapeutic benefit. In future trials, the company will continue to explore additional routes of administration that will enable optimal drug distribution, including direct injection into the relevant tissues.

How 4975 May Address Need for Long-Duration, Well-Tolerated Pain Relief

4975 is long-acting, with the potential to provide pain relief for weeks or months after just a single treatment. It is a non-opioid TRPV1 agonist based on capsaicin. Its unique mechanism of action provides a long-lasting, localized effect on C-fibers, and blocks the transmission of aching, throbbing pain caused by major surgical procedures. Because it selectively acts on nerve endings, 4975 does not affect other nerve fibers necessary for sensory or motor sensations, such as those needed to sense temperature or pressure.

In clinical studies to date, 4975 has not had the side effects often associated with other pain medications and has been shown to be well tolerated. Opioid drugs, such as morphine, which are commonly used agents to relieve pain in post-surgical and musculoskeletal pain conditions, have significant side effects including sedation, respiratory depression, euphoria, and nausea and vomiting during acute use, and constipation and physical dependence during chronic use.

About Corgentech

Corgentech is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. The company has four drug candidates in clinical development for multiple potential indications, the most advanced of which, 3268, has completed Phase 3 clinical trials. To reflect the company's core focus on novel pain management therapies, the board of directors recently voted to change the company name to Anesiva. If approved by stockholders at the annual meeting on June 21, 2006, the name change will become effective immediately thereafter, and the stock is anticipated to trade under the Nasdaq symbol: ANSV. Corgentech is based in South San Francisco, CA.

Forward Looking Statements

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release include, without limitation, projected timing of clinical development and other matters that involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. Such risk factors include, among others: whether Corgentech can successfully develop new products and the degree to which these gain market acceptance. Actual results may differ materially from those contained in the forward-looking statements in this press release. Additional information concerning these and other risk factors is contained in Corgentech's quarterly report on Form 10-Q for the quarter ended March 31, 2006. Corgentech undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement.

Specialized in: Corgentech Pain Drug - 4975 - Demonstrates Statistically - Significant Pain Reduction - Replacement Surgeries
URL: http://www.corgentech.com
Print press release      Bookmark this page
Related Press releases 
Clarity Surgical Proudly Announces Their New Weight Loss Surgeon: Dr. Owen Pyke, MD (Popularity: ): Clarity Surgical is proud to announce their newest hire: Dr. Owen Pyke, MD!Long Island, NY - USA, October 20, 2020 -- Clarity Surgical is proud to announce their newest hire: Dr. Owen Pyke, MD! He joined the Clarity Surgical team on September 8th and will be taking on the role of general and weight loss surgeon.Dr. Owen Pyke originally hails from the island nation of Jamaica. His family immigrated to ...
Dr Leeds Introduces Telemedicine Services to Ensure Safe Treatment During the COVID-19 Pandemic (Popularity: ): Fort Lauderdale, FL - USA | June 3rd, 2020 -- The current pandemic due to COVID-19 has forced the world to go indoors by practicing social distancing and adhering to lockdown instructions globally. These are the times that call for solidarity and unity to fight the situation until the world comes back to its normal being. In such challenging times, the medical experts at Dr Leeds have introduced telemedicine in ...
The launch of Meddco Android App with new features to make healthcare affordable (Popularity: ): MUMBAI, India, 20 JULY, 2019 -​​​ Meddco.com® is pleased to announce the reintroduction of its Android and iOS Mobile App and its latest functionality which aims to improve the health of everyday people. The addition of new features made to the Android and iOS app will help patients compare the prices of different healthcare services and choose the most suitable one with a single click. Moreover, it includes dynamic pricing, ...
Bethesda MD In-Home Care Agency Educates Readers On Mental Exercises (Popularity: ): Rockville, Maryland ( press.abc-directory.com ) January 22, 2019 - Comfort Home Care, a Bethesda Maryland in-home care agency, released a guide for people with elderly loved ones outlining mental exercises for strengthening memory and cognition. The Maryland in-home care agency recommends that family members help elderly loved ones incorporate these exercises into their regular routines to promote better mental health.As our loved ones age, their mental abilities often decline. Reduced ...
Tooth Implant Sydney Now Announces to Offer High Quality and Affordable Dental Implant (Popularity: ): Sydney, New South Wales ( press.abc-directory.com ) March 26, 2018 - Having missing teeth is not only embarrassing but the mouth will deteriorate rapidly if left untreated. Dental implants help you look and feel better, regain your self-esteem, and have a better quality of life. Understanding the importance of dental implants and to help edentulous patients to get high quality and affordable dental implants, Tooth Implant Sydney now proudly offers ...

Press release home snapshot 


Related Business 
Knee Pain Diagnosis (Popularity: ): This website guides people in understanding the proper way of diagnosing the causes of knee pain. For knee pain conditions, knee pain diagnosis is the first step in order to find the right treatment for it. You should know that knee pain conditions can be due to various conditions and if left untreated, this may lead to severe knee pain that can disrupt daily activities.
Knee Replacement (Popularity: ): Get information on knee joint pain, knee replacement, knee cap replacement and knee surgery. The complication, risks, exercises, rehab and all the info you need to know is here.
Ayurvedic Oil For Muscle Pain (Popularity: ): If you are suffering with pain and stiffness from conditions such as arthritis, knee pain, back pain, joint pain, neck pain or shoulder pain then Himalaya Natural oil for back pain is for you. This anti inflammatory pain relief oil is natural safe effective and extract from herbs and rare plants found in the Himalayan region.
Pain Management In Boynton Beach (Popularity: ): Palm Beach Pain Institute offers expert treatment for critical pain and injuries including back pain, neck, shoulder, knee pain, arthritis, osteoporosis, osteoarthritis, peripheral neuropathy, pelvic pain and much more with utmost care and compassion.
Online Pharmacy USA (Popularity: ): Tramadol use to treat moderate pain such as low back pain, shoulder pain, neck pain, knee pain, cancer or joint pain. It works in the brain to change how your body feels and responds to pain. Relipharm.com helps you to buy tramadol online as overnight delivery without prescription in USA.
Pharmacy Rx World (Popularity: ): Hyalgan is a source of sodium hyaluronate. It is injected directly into the knee joint and is used to relieve knee pain due to osteoarthritis. It is injected directly into the knee joint and is used to relieve knee pain due to osteoarthritis. It is recommended in cases where physical therapy, exercise or pain killers have failed to relieve pain.
Integrative Pain Clinic (Popularity: ): Integrative Pain Clinic is a PA based pain clinic gives medical treatment such as epidural pain treatment, hip joint pain treatment, neck pain treatments etc. Our clinic doctors are well certified & experienced and having latest technology machine for best treatment. Integrative Pain Clinic is one of the best relible and certified Pain doctor and providing pain relief treatment solution in West Chester, PA, Pain Medicine Clinic, Knee Pain Treatments ...
Whittington Chiropractic (Popularity: ): Some concerns that have been frequently addressed by our Asheville chiropractic office include: neck pain, shoulder pain, headache, migraine headache, low back pain, lumbar disk problems, sciatica, cervical disk problems and radiation into arms and hands, knee pain, foot pain, ankle pain, elbow pain, wrist pain, carpal tunnel, hiatal hernia and acid reflux, rehabilitation exercises and stretches, and nutrition.
Physassist Foot Pain Cream (Popularity: ): PhysAssist? Foot Pain Cream with Tea Tree was introduced to the market in 2001 by J S Ransdell and his wife Margoth. In the nine plus years the company has served tens of thousands of customers throughout North America. We are manufacturer of Foot Pain Cream, Knee Pain Cream, Leg Pain Cream, Ankle Pain Cream, Burning Sensation, Neuropathy Pain Cream, Burning Pain, Swollen Feet, Nerve Pain, Nerve Damage, Plantar Fasciitis ...
Plains Physiotherapy (Popularity: ): Clinic based in Nottingham, England specialize in back pain, neck pain, knee pain and sports injuries.